Impact of biologically effective dose on tremor decrease after stereotactic radiosurgical thalamotomy for essential tremor: a retrospective longitudinal analysis
- PMID: 38296852
- PMCID: PMC10830596
- DOI: 10.1007/s10143-024-02296-1
Impact of biologically effective dose on tremor decrease after stereotactic radiosurgical thalamotomy for essential tremor: a retrospective longitudinal analysis
Abstract
Stereotactic radiosurgery (SRS) is one of the surgical alternatives for drug-resistant essential tremor (ET). Here, we aimed at evaluating whether biologically effective dose (BEDGy2.47) is relevant for tremor improvement after stereotactic radiosurgical thalamotomy in a population of patients treated with one (unplugged) isocenter and a uniform dose of 130 Gy. This is a retrospective longitudinal single center study. Seventy-eight consecutive patients were clinically analyzed. Mean age was 69.1 years (median 71, range 36-88). Mean follow-up period was 14 months (median 12, 3-36). Tremor improvement was assessed at 12 months after SRS using the ET rating assessment scale (TETRAS, continuous outcome) and binary (binary outcome). BED was defined for an alpha/beta of 2.47, based upon previous studies considering such a value for the normal brain. Mean BED was 4573.1 Gy2.47 (median 4612, 4022.1-4944.7). Mean beam-on time was 64.7 min (median 61.4; 46.8-98.5). There was a statically significant correlation between delta (follow-up minus baseline) in TETRAS (total) with BED (p = 0.04; beta coefficient - 0.029) and beam-on time (p = 0.03; beta coefficient 0.57) but also between TETRAS (ADL) with BED (p = 0.02; beta coefficient 0.038) and beam-on time (p = 0.01; beta coefficient 0.71). Fractional polynomial multivariate regression suggested that a BED > 4600 Gy2.47 and a beam-on time > 70 min did not further increase clinical efficacy (binary outcome). Adverse radiation events (ARE) were defined as larger MR signature on 1-year follow-up MRI and were present in 7 out of 78 (8.9%) cases, receiving a mean BED of 4650 Gy2.47 (median 4650, range 4466-4894). They were clinically relevant with transient hemiparesis in 5 (6.4%) patients, all with BED values higher than 4500 Gy2.47. Tremor improvement was correlated with BED Gy2.47 after SRS for drug-resistant ET. An optimal BED value for tremor improvement was 4300-4500 Gy2.47. ARE appeared for a BED of more than 4500 Gy2.47. Such finding should be validated in larger cohorts.
Keywords: Biologically effective dose; Essential tremor; Radiosurgery; TETRAS.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures




Similar articles
-
Impact of biologically effective dose on tremor decrease after stereotactic radiosurgical thalamotomy for essential tremor: a retrospective longitudinal analysis.Neurosurg Rev. 2024 Mar 19;47(1):122. doi: 10.1007/s10143-024-02361-9. Neurosurg Rev. 2024. PMID: 38502283
-
Impact of the Mean Cochlear Biologically Effective Dose on Hearing Preservation After Stereotactic Radiosurgery for Vestibular Schwannoma: A Retrospective Longitudinal Analysis.Neurosurgery. 2024 Jan 1;94(1):174-182. doi: 10.1227/neu.0000000000002609. Epub 2023 Jul 11. Neurosurgery. 2024. PMID: 37431994 Free PMC article.
-
Pretherapeutic resting-state fMRI profiles are associated with MR signature volumes after stereotactic radiosurgical thalamotomy for essential tremor.J Neurosurg. 2018 Dec 1;129(Suppl1):63-71. doi: 10.3171/2018.7.GKS18752. J Neurosurg. 2018. PMID: 30544321
-
Gamma Knife® stereotactic radiosurgery as a treatment for essential and parkinsonian tremor: long-term experience.Neurologia (Engl Ed). 2023 Apr;38(3):188-196. doi: 10.1016/j.nrleng.2020.05.025. Epub 2022 Mar 16. Neurologia (Engl Ed). 2023. PMID: 35305964 Review.
-
Radiosurgical thalamotomy for essential tremor: state of the art, current challenges and future directions.Expert Rev Neurother. 2024 Jun;24(6):597-605. doi: 10.1080/14737175.2024.2351512. Epub 2024 May 7. Expert Rev Neurother. 2024. PMID: 38713485 Review.
Cited by
-
Impact of biologically effective dose on tremor decrease after stereotactic radiosurgical thalamotomy for essential tremor: a retrospective longitudinal analysis.Neurosurg Rev. 2024 Mar 19;47(1):122. doi: 10.1007/s10143-024-02361-9. Neurosurg Rev. 2024. PMID: 38502283
-
Stereotactic radiosurgery in the treatment of essential tremor - a systematic review.Front Neurol. 2024 Apr 3;15:1370091. doi: 10.3389/fneur.2024.1370091. eCollection 2024. Front Neurol. 2024. PMID: 38633530 Free PMC article.
References
-
- Bain PG, Findley LJ, Thompson PD, Gresty MA, Rothwell JC, Harding AE, Marsden CD (1994) A study of hereditary essential tremor. Brain 117(Pt 4):805–824. 10.1093/brain/117.4.805 - PubMed
-
- Barendsen GW (1982) Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys 8:1981–1997. 10.1016/0360-3016(82)90459-x - PubMed
-
- Benabid AL, Pollak P, Louveau A, Henry S, de Rougemont J (1987) Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol 50:344–346. 10.1159/000100803 - PubMed
-
- Berger A, Alzate JD, Bernstein K, Mullen R, McMenomey S, Jethanemest D, Friedmann DR, Smouha E, Sulman EP, Silverman JS, Roland JT, Golfinos JG, Kondziolka D (2022) Modern hearing preservation outcomes after vestibular schwannoma stereotactic radiosurgery. Neurosurgery 91:648–657. 10.1227/neu.0000000000002090 - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources